- Home
- FRPH vs ORIC Comparison
FRPH vs ORIC Comparison
Compare FRPH & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRPH
- ORIC
- Stock Information
- Founded
- FRPH 1986
- ORIC 2014
- Country
- FRPH United States
- ORIC United States
- Employees
- FRPH N/A
- ORIC N/A
- Industry
- FRPH Real Estate
- ORIC Biotechnology: Pharmaceutical Preparations
- Sector
- FRPH Finance
- ORIC Health Care
- Exchange
- FRPH Nasdaq
- ORIC Nasdaq
- Market Cap
- FRPH 459.4M
- ORIC 1.1B
- IPO Year
- FRPH N/A
- ORIC 2020
- Fundamental
- Price
- FRPH $25.04
- ORIC $12.97
- Analyst Decision
- FRPH
- ORIC Strong Buy
- Analyst Count
- FRPH 0
- ORIC 8
- Target Price
- FRPH N/A
- ORIC $16.57
- AVG Volume (30 Days)
- FRPH 53.3K
- ORIC 1.5M
- Earning Date
- FRPH 11-10-2025
- ORIC 11-11-2025
- Dividend Yield
- FRPH N/A
- ORIC N/A
- EPS Growth
- FRPH N/A
- ORIC N/A
- EPS
- FRPH 0.28
- ORIC N/A
- Revenue
- FRPH $32,293,999.00
- ORIC N/A
- Revenue This Year
- FRPH N/A
- ORIC N/A
- Revenue Next Year
- FRPH N/A
- ORIC N/A
- P/E Ratio
- FRPH $89.24
- ORIC N/A
- Revenue Growth
- FRPH 3.18
- ORIC N/A
- 52 Week Low
- FRPH $23.52
- ORIC $3.90
- 52 Week High
- FRPH $33.00
- ORIC $14.93
- Technical
- Relative Strength Index (RSI)
- FRPH 52.08
- ORIC 55.15
- Support Level
- FRPH $24.57
- ORIC $11.71
- Resistance Level
- FRPH $25.55
- ORIC $14.17
- Average True Range (ATR)
- FRPH 0.52
- ORIC 0.75
- MACD
- FRPH 0.11
- ORIC -0.20
- Stochastic Oscillator
- FRPH 68.85
- ORIC 40.06
About FRPH FRP Holdings Inc.
FRP Holdings Inc is a holding company engaged in various real estate businesses. The company's business segments are Leasing and management of commercial properties owned by the company (the Industrial/Commercial Segment); Leasing and management of mining royalty land owned by the company (the Mining Royalty Lands Segment); real property acquisition, entitlement, development and construction for apartment, retail, warehouse, and office buildings either alone or through joint ventures (the Development Segment); ownership, leasing and management of buildings through joint ventures (the Multifamily Segment).
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.